Pancreatic cancer develops when cells in the pancreas begin dividing abnormally, forming a tumor. The pancreas is located deep within the abdomen, posterior to the stomach, and serves two primary functions: the exocrine production of digestive enzymes and the endocrine regulation of blood glucose through insulin secretion.
This is a primary reason why pancreatic cancer is frequently diagnosed at an advanced stage, often after the disease has spread beyond the pancreas.
When early symptoms do present, they typically resemble common gastrointestinal complaints, mild abdominal discomfort, reduced appetite, or unexplained weight loss and are rarely associated with a serious underlying malignancy at initial presentation.
Pancreatic cancer is not among the most prevalent malignancies, but it presents one of the greatest challenges in oncology in terms of treatment response and overall prognosis.
In India, incidence has risen steadily, particularly in urban populations, a trend associated with changing dietary patterns and the increasing prevalence of type 2 diabetes, both recognized risk factors.
Two factors contribute significantly to late-stage diagnosis: early symptoms closely resemble common gastrointestinal complaints and are frequently overlooked, and no validated routine screening tool exists for pancreatic cancer comparable to those established for breast or cervical cancer.
Early detection remains possible, however, and requires heightened clinical vigilance and patient awareness of early warning signs.
Not all pancreatic cancers behave the same way. The type determines growth speed, treatment approach, and expected response:
Exocrine pancreatic cancer
Neuroendocrine pancreatic cancer (NETs)
Adenocarcinoma
Acinar Cell Carcinoma
Squamous cell carcinoma
Adenosquamous Carcinoma
Intraductal Papillary Mucinous Neoplasm (IPMN)
Mucinous Cystic Neoplasm (MCN)
Put simply, adenocarcinoma accounts for the vast majority of cases. Neuroendocrine tumors are rarer but tend to grow more slowly; actually, that distinction shapes the entire treatment strategy. Each type responds differently to chemotherapy, surgery, and targeted therapy, so identifying the type isn't just academic.
Staging maps how far the cancer has traveled. It's a bit like tracking how far water damage has spread through a building:
TNM system
The most common pancreatic cancer risk factors are linked to a combination of genetic, lifestyle, and medical factors that can increase the likelihood of developing the disease.
Several factors push pancreatic cells toward cancerous changes. In India, some of these risk factors are more prevalent than in other parts of the world.
In most cases, though not all, pancreatic cancer develops due to a combination of influences rather than a single trigger. Having one risk factor does not mean cancer is inevitable, but understanding your risk profile can help support early awareness and timely medical evaluation.
Pancreatic cancer prevention won't say outright is that managing diabetes and chronic pancreatitis properly can meaningfully lower the risk. Think of prevention as stacking the odds in your favor:
A pancreatic cancer diagnosis doesn't come from a single test. It's like peeling back layers of an onion. First, blood tests and imaging flag the concern. Second, specialized scans narrow the target. Third, a biopsy confirms the diagnosis.
But because the pancreas isn't easy to access, some of these tests require specialized equipment and experienced hands.
CT Scan
MRI
Endoscopic Ultrasound
Positron Emission Tomography (PET) Scan
The most effective pancreatic cancer treatment depends on the type, stage, and whether the tumor can be surgically removed. Or rather, the first question surgeons ask is whether the tumor is resectable, because that shapes everything that follows. If it can be removed, surgery gives the best chance. If it can't, chemotherapy and targeted therapy become the main line of defense:
Whipple Procedure (Pancreaticoduodenectomy)
Distal Pancreatectomy
Total Pancreatectomy
Gastroenterologists and oncologists at HCG Cancer Hospital in Bengaluru, Mumbai, Ahmedabad, and Kolkata handle pancreatic cancer from initial imaging through surgical and medical treatment. The honest answer is that pancreatic cancer outcomes depend heavily on getting to the right team quickly.
And HCG Cancer Hospital's multi-disciplinary approach means surgical, medical, and radiation oncologists review each case together before any treatment starts.
But even patients with advanced pancreatic cancer get structured palliative care and symptom management.
You can't prevent pancreatic cancer entirely; well, almost always, the unpreventable factors are out of your hands. But these steps help bring the risk down. Think of each measure as removing one domino from a chain reaction:
Pancreatic cancer remains one of oncology's toughest challenges, largely because its early symptoms, mild abdominal discomfort, reduced appetite, and unexplained weight loss closely resemble common gastrointestinal complaints, leading to diagnosis at a later stage in many cases.
With no validated routine screening tool available, awareness of risk factors like tobacco use, chronic pancreatitis, diabetes, and family history becomes especially important for early detection.
Diagnosis relies on a layered approach combining blood tests, imaging, and biopsy, while treatment options depend heavily on whether the tumor can be surgically removed, ranging from the Whipple procedure to chemotherapy, targeted therapy, and immunotherapy.
At HCG Cancer Hospital centers in Bengaluru, Mumbai, Ahmedabad, and Kolkata, gastroenterologists and oncologists work together from diagnosis through treatment, ensuring even advanced cases receive structured, multi-disciplinary care and support.
Feel free to reach out to us.
